Supplementary Methods from Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways — Henk van Ooijen (2023) | RDL Network
Supplementary Methods from Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
Preprint 2023 en
Authors
HO
Henk van Ooijen
MI
Márcia A. Inda
PH
Pantelis Hatzis
Abstract
1 min read
<p>PDF file - 174KB, Details of the modeling approach, selected genes and probesets, and additional results. Also includes supplementary references.</p>
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Wim Verhaegh, Henk van Ooijen, Márcia A. Inda, Pantelis Hatzis, Rogier Versteeg, Marcel Smid, John W.M. Martens, John A. Foekens, Paul van de Wiel, Hans Clevers, Anja van de Stolpe
Discussion(0)
No comments yet. Be the first to comment.